FTC Secures Proposed Record $12 Million Penalty Against Edwards Lifesciences for Alleged HSR Filing Violation
The FTC obtained a proposed record $12M penalty against Edwards and Genesis, alleging they structured a 2024 med-tech deal to dodge HSR filing requirements.